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S U M M A R Y
Tuberculosis is a signiﬁcant public health problem that continues to be a major cause of morbidity and
mortality worldwide. Tuberculous meningoencephalitis (TM) is the most common extrapulmonary lesion
in tuberculosis. A 41-year-old female was thought to have TM. Tests to conﬁrm the TM diagnosis were
initially negative, including tuberculosis PCR and adenosine deaminase level in serum and cerebrospinal
ﬂuid (CSF). Anti-tuberculous medication and intravenous steroids were administered to her on the basis of
brain imaging and lactate dehydrogenase electrophoresis in CSF, suggestive of the diagnosis of TM. Her
neurological problems improved rapidly following treatment. Serologic and CSF markers were positive in
PCR and culture after 60 days. Radiological ﬁndings are often nonspeciﬁc and TM is difﬁcult to diagnose
without an increased index of suspicion. The detection of paradoxical expansion of tuberculoma is very
important in the maintenance of medication. Magnetic resonance imaging was used to detect paradoxical
expansion of the tuberculoma using various methods, such as contrast-enhanced ﬂuid-attenuated
inversion recovery (CE-FLAIR) imaging. CE-FLAIR imaging conspicuously showed paradoxical expansion
of the tuberculoma. If patients present with clear meningitis, without any identiﬁed pathogen, there is a
need to constantly and scrupulously check for TM, including with the use of CE-FLAIR brain imaging.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-
nc-sa/3.0/).
Contents lists available at ScienceDirect
International Journal of Infectious Diseases
jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Tuberculous meningoencephalitis (TM) is the most common
extrapulmonary lesion in tuberculosis, presenting with various
symptoms. It occurs particularly in developing countries, affecting
up to 15% of the population in such countries.1 The serological and
radiological ﬁndings are often nonspeciﬁc, and TM is difﬁcult to
diagnose without an increased index of suspicion. Serial serologi-
cal diagnosis is not speciﬁc for TM. Follow-up magnetic resonance
imaging (MRI) may suggest a paradoxical expansion of the
tuberculoma, providing a clue for the treatment of TM.
Here we report ﬁndings from a patient with TM, which was
conﬁrmed by abnormal signals on contrast-enhanced ﬂuid-
attenuated inversion recovery (CE-FLAIR) MRI; this suggested
paradoxical tuberculoma.
2. Case report
A 41-year-old female was admitted with mild Parkinsonism,
presenting with involuntary movements of her left side and* Tel.: +82 2 2290 8374; fax: +82 2 2290 8371.
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month. Her vital signs were stable. Upon neurological
examination, she exhibited right upper and lower limb
weakness (grade IV/grade IV) with intermittent clonic move-
ments on the left side. She was mentally alert, but appeared
disorientated and irritated.
Initial cerebrospinal ﬂuid (CSF) ﬁndings showed leukocytosis
with lymphocyte dominance, without protein elevation (white
blood cell count 220  106/l, red blood cell count 6  106/l, and
protein 46 mg/dl). Tests to conﬁrm the TM diagnosis were initially
negative, including tuberculosis PCR and adenosine deaminase
(ADA) level in serum and CSF.
The involuntary movements and hemiparesis on the left side
became worse in the 7 days after admission. There were high signal
changes on CE-FLAIR imaging in the right temporo-parietal regions
(Figure 1A). Contrast-enhanced T1-weighted imaging showed a
lack of enhancement in the same area (Figure 1B). Anti-
tuberculous medication and intravenous steroids were adminis-
tered to her on the basis of the brain imaging and lactate
dehydrogenase (LD) electrophoresis in CSF, suggestive of the
diagnosis of TM (increased total LD up to 47 IU/l (normal value 28
IU/l), increased LD3 and LD4 fractions, and decreased LD1). Her
neurological problems had resolved completely 30 days after
starting medication.ciety for Infectious Diseases. This is an open access article under the CC BY-NC-SA
Figure 1. (A) Hospital day 1: Contrast-enhanced FLAIR images showing slight leptomeningeal enhancement in the right temporo-parietal region (arrows). It is difﬁcult to
differentiate tuberculosis meningitis from other diseases showing high signal intensity within the sulci. (B) Hospital day 1: Contrast-enhanced T1-weighted images. (C)
Hospital day 60: Contrast-enhanced FLAIR images conspicuously showing high signals in right peripontine and left medio-temporal regions (arrows). (D) Hospital day 60:
Contrast-enhanced T1-weighted images. The contrast-enhanced T1-weighted images showed no evidence in the same areas.
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signals within the right hemispheric region that were conspicu-
ously present in the right peripontine and left medial temporal
regions on CE-FLAIR; this was suggestive of paradoxical expansion
of the tuberculoma (Figure 1C). There were no abnormal signals on
contrast-enhanced T1-weighted images of the same regions
(Figure 1D). Serologic and CSF markers were positive by PCR
and culture at the same time. We decided to continue medicationfor 1 year, based on the paradoxical granuloma in the brain CE-
FLAIR images of the left peripontine area.
3. Discussion
A diagnosis of deﬁnite TM is only made when acid-fast bacilli
(AFB) are seen, or when Mycobacterium tuberculosis is cultured or
detected by a reliable molecular method from the CSF in someone
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have reported the detection of AFB and culture isolation of M.
tuberculosis from the CSF to be easily detected, but most are
exceptional.3
The rapid diagnosis of TM is very important because most
affected patients die, and any delay in treatment results in
signiﬁcant morbidity.2 The mortality rates vary from 7% to 45%,
and the optimum therapeutic regimen for various presentations of
central nervous system tuberculosis have not yet been deter-
mined.4 The CSF PCR assay represents a signiﬁcant advance in the
diagnosis of microbial diseases, and TM is no exception. The results
of PCR studies in the CSF have shown a speciﬁcity of 94–100%, but
sensitivities range from 75% to 100%.3 MRI can aid in the diagnosis
of TM. The detection of secondary resistance, atypical mycobacte-
rial infection, and paradoxical spread of the tuberculoma have
come to the fore in TM.
A paradoxical response after anti-tubercular therapy is deﬁned
as a transient worsening of disease at a pre-existing site, or the
development of new tuberculous lesions in a patient who initially
improved on anti-tubercular therapy. This phenomenon is more
commonly associated with extrapulmonary tuberculosis.1 Initially,
the explanation for the paradoxical expansion of the tuberculoma
was that it could be indicative of a blood–brain barrier (BBB)
breakdown, drug resistance, enhanced anti-tuberculous immune
response, or irregular medication.2 The detection of this phenom-
enon is necessary for treatment maintenance. The enhancement is
much more conspicuous on CE-FLAIR images. Additional enhance-
ment is present in several inferior and lateral sulci in the right
temporo-parietal and left frontal regions. CE-FLAIR can be more
conspicuously detected in a BBB breakdown, increased protein
content, or CSF outﬂow disturbance than in routine contrast-
enhanced T1-weighted imaging.5
This patient started anti-tuberculous medication without any
evidence from laboratory tests to support this action. TM
serological markers, including PCR, were negative 60 days aftertreatment. Only the abnormal signals in the CE-FLAIR images had
important implications for the commencement and ongoing
treatment with anti-tuberculous medication in this patient.
Standardized diagnostic criteria for TM have not been established,
and most reports have used different case deﬁnitions. Since there
are no standardized criteria, there is a limit in using existing data to
apply to diagnosis and treatment.2 If patients present with clear
meningitis, without any identiﬁed pathogen, there is a need to
constantly and scrupulously check for TM, including with the use
of CE-FLAIR brain imaging.
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